Moreover, β-catenin is involved in maintaining the survival of LSCs that are insensitive to kinase inhibition in mice with BCR-ABL-induced CML [9]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.